Home Cart Sign in  
Chemical Structure| 484049-04-9 Chemical Structure| 484049-04-9

Structure of DPH
CAS No.: 484049-04-9

Chemical Structure| 484049-04-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DPH is a potent cell permeable c-Abl activator, which displays potent enzymatic and cellular activity in stimulating c-Abl activation.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DPH

CAS No. :484049-04-9
Formula : C18H13FN4O2
M.W : 336.32
SMILES Code : O=C1NC(C(C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(F)C=C4)N1)=O
MDL No. :MFCD03268950

Safety of DPH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of DPH

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
4T1 cells 10 µg/mL nanoparticles 24 hours M(I + D)PH treatment significantly increased the apoptosis ratio of 4T1 cells, with a survival rate of 38.24%. J Nanobiotechnology. 2024 Jun 19;22(1):346.
Neonatal rat ventricular myocytes 250 or 500 nM 48 hours inhibition of Ang II-induced hypertrophic gene expression Proc Natl Acad Sci U S A. 2019 May 14;116(20):10156-10161.
HEK293T cells 500 nM inhibition of TRPC6-mediated NFAT activity Proc Natl Acad Sci U S A. 2019 May 14;116(20):10156-10161.
Mouse bone-marrow-derived macrophages 2 × 10^-6 M 1 min Measured membrane fluidity, showing the same fluidity in endocytosed membrane as in the plasma membrane J Cell Biol. 1994 May;125(4):783-94.
L929 mouse fibroblasts 2 × 10^-6 M 10 s to 90 min Investigated TMA-DPH as a marker for the endocytic pathway, showing its internalization from the cell periphery to perinuclear regions without noticeable loss in fluorescence intensity J Cell Biol. 1994 May;125(4):783-94.
HepG2 cells 10 μM DPH 30 minutes To measure ER membrane fluidity, results showed that HFD or TG treatment reduced ER membrane fluidity, and DPH polarization was eliminated by increasing temperature. Acta Pharmacol Sin. 2023 Jan;44(1):133-144.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice DSS-induced colitis model Intraperitoneal injection 70 mg/kg Once daily for 12 days DPH treatment significantly attenuated DSS-induced colitis symptoms, characterized by reduced weight loss, increased colon length, and decreased immunologic injury. Sci Adv. 2021 May 7;7(19):eabe5171
Mice Pressure overload model Oral gavage 30 mg/kg/day Once daily for 8 weeks Improves cardiac function, reduces fibrosis gene expression and interstitial fibrosis Proc Natl Acad Sci U S A. 2019 May 14;116(20):10156-10161.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.97mL

0.59mL

0.30mL

14.87mL

2.97mL

1.49mL

29.73mL

5.95mL

2.97mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories